Skip to content
Home » Valentine's Day » FDA advisory panel votes unanimously to approve Johnson & Johnson booster vaccine

FDA advisory panel votes unanimously to approve Johnson & Johnson booster vaccine

The Johnson & Johnson booster vaccine has been unanimously voted to be approved by the FDA advisory panel.

The emergency use authorization would allow adults 18 and older to get a booster shot two months after a vaccination.

The 19-0 vote was made after evidence from the phase three trials showed increased protection by 94% against moderate to severe COVID-19.



Categories: HealthNews

Top